A Special Lecture Presented by:
With
Presenters and Panelists:
Lourdes Baezconde-Garbanati, PhD, MPH, MA
Keck School of Medicine of USC
Terry D. Church, DRSc, MA, MS
USC Institute for Addiction Science & USC Alfred E. Mann School of Pharmacy
Brian P. Lee, MD
Keck School of Medicine of USC
Stephen J. Pandol, MD
Cedar Sinai Medical Center & David Geffen School of Medicine at UCLA
|
This lecture series event is designed for providers and clinicians of the SAPC network and will provide a detailed review of the negative health impacts of alcohol consumption, especially as it relates to liver and pancreatic diseases. Specifically, this lecture will address the synergistic effect of alcohol and secondary risk factors such as diet and viral hepatitis on the development and progression of alcohol associated liver and pancreatic diseases (ALPD). Based on scientific studies, the Southern California Research Center for ALPD and Cirrhosis believes the best approach to understanding ALPD is to define the relationship between the diseases and these risk factors. This allows for the development of more effective prevention and treatment measures to be utilized by healthcare professionals. Through this lecture, participants will learn about the risk factors for ALPD, gain a deeper understanding of alcohol associated diseases in the community, and learn about current treatment options for alcohol use disorder and ALPD. A panel discussion with the presenters will follow the presentations which will allow for greater discussion and deepening in knowledge, translating into meaningful encounters substance use providers may have with patients. Please see the flyer for more details including the learning objectives. The panel portion of the lecture series event will feature Los Angeles County-based providers sharing what their agency has done to help support their providers in dealing with grief and loss in the field. Helpful resources will be shared including how to support SUD treatment providers. |
Objectives:
At the end of this presentation, participants will be able to:
1. Identify two (2) population groups at risk for liver and pancreatic diseases as a result of their alcohol consumption and how alcohol correlates to these diseases.
2. Explain two (2) reasons why alcohol associated liver disease is connected to metabolic dysfunction (MetALD).
3. Specify two (2) assessment options and two (2) treatment options for Alcohol Use Disorder.
4. Describe three (3) individual behavioral and three (3) health factors which may increase the risk of liver and pancreatic diseases among persons consuming alcohol.
Research reported in this presentation was supported by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under Award #P50AA011999. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
The training course meets the qualifications for the provision of three (3.0) continuing education credits/ contact hours (CEs/CEHs). UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course and its content. Course meets the qualifications for three (3.0) hours of continuing education credit for LMFTs, LCSWs, LPCCS, and LEPs as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider of continuing education for RADTs I/II, CADCs-CASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-00-445-1123), CATCs (ACCBC/CAADE, #CP40 872 C 0822), and CAODCs (CADTP, #151).
CE credit will be awarded six-eight weeks after the virtual training. Partial credit will not be available for those participants who arrive late or leave early.
UCLA Integrated Substance Abuse Programs (ISAP) is approved by the American Psychological Association to sponsor continuing education for psychologists. UCLA ISAP maintains responsibility for this program and its content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the
California Medical Association (CMA) through the joint providership of UCLA Integrated Substance Abuse Programs (ISAP) and SAPC. UCLA Integrated Substance Abuse Programs (ISAP) is accredited by the CMA to provide continuing medical education for physicians.
UCLA Integrated Substance Abuse Programs (ISAP) designates this live virtual training course for a maximum of three (3.0) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 CreditsTM (rn.ca.gov). Nurses will receive a Certificate of Participation following this activity that may be used for license renewal. Continuing medical education will be awarded within 6-8 weeks following completion of the training.
Instructions for Filing a Grievance Concerning UCLA ISAP’s Continuing Education Program:
Please contact Dr. Thomas E. Freese, CE Program Administrator, in writing (UCLA ISAP, 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90024-2886) or by phone (310-267-5397). Alternately, you may contact Dr. Gloria Miele or Dr. James Peck, ISAP-affiliated doctoral-level psychologists responsible for program planning for the ISAP CE Program. Drs. Miele and Peck can be reached in writing at: 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90024-2886 or by phone at: 310-267-5888 (Miele) or 310-267-5346 (Peck).
Please contact Brandy Oeser at 310-267-5331 or via email at [email protected] if you have questions or concerns.
If you need a disability-related reasonable accommodation/alternative format for this event, please contact Brandy Oeser at (310) 267-5331 or via email at [email protected] by September 23, 2022.
This lecture series will be recorded.
Refund/Cancellation Policy: Notice of cancellation must be made at least 72 hours in advance of the training by emailing Brandy Oeser at [email protected]. You can also cancel directly via zoom.
Pre-registration is required and enrollment is limited to 1000 people. Registration will be accepted on a first come, first served basis.
You will receive a zoom confirmation if space has been reserved for you.
Funding for this lecture was made possible in part by cooperative agreement 5UR1TI080211-02 from the Substance Abuse and Mental Health Services Administration.
